Madrigal Pharmaceuticals (MDGL) Debt Ratio (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Debt Ratio of 0.27 for Q2 2026, up 134.86% year-over-year from 0.12 in Q2 2025, and down 1.26% quarter-over-quarter from 0.28 in Q1 2026.
Madrigal Pharmaceuticals (MDGL) Debt Ratio (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Debt Ratio for 12 consecutive years, with 0.27 the latest figure, recorded in Q2 2026.
- In Q2 2026, Debt Ratio rose 134.86% year-over-year to 0.27; the TTM figure through Jun 2026 stood at 0.27 (up 134.86% YoY), while the FY2025 annual figure was 0.27, up 139.21% from the prior year.
- Debt Ratio retreated to 0.27 in Q2 2026 per MDGL's latest filing, from 0.28 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.63 in Q3 2023 and bottomed at 0.11 in Q2 2024.
- Historically, Debt Ratio has averaged 0.25 across 5 years, with a median of 0.25 in 2025.
- Annual changes were most pronounced in 2024 — Debt Ratio slumped 82.56% — and 2025, when it soared 139.21%.
- Madrigal Pharmaceuticals' Debt Ratio stood at 0.14 in 2022, then surged by 32.62% to 0.18 in 2023, then slumped by 37.43% to 0.11 in 2024, then soared by 139.21% to 0.27 in 2025, then climbed by 1.47% to 0.27 in 2026.
- Business Quant data shows MDGL's Debt Ratio at 0.27 in Q2 2026, 0.28 in Q1 2026, and 0.27 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.27 |
| Mar 31, 2026 | 0.28 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.63 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.31 |
| Jun 30, 2022 | 0.22 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.04 |
| Dec 31, 2015 | 12.67 |